| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.004 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.006 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.006 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.006 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.68 | 0.007 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.008 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.008 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.09 | 0.008 |